Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Marlana Orloff"'
Autor:
John M. Kirkwood, Ryan J. Sullivan, Jessica C. Hassel, Shaad Essa Abdullah, Piotr Rutkowski, Sophie Piperno-Neumann, Joseph J. Sacco, Max Schlaak, Marcus O. Butler, Josep M. Piulats, Sebastian Ochsenreither, Jean-François Baurain, Anthony M. Joshua, Paul C. Nathan, Reinhard Dummer, Sarah Lockwood, Alexander N. Shoushtari, Marlana Orloff, Mughda Deo
Publikováno v:
Journal of Clinical Oncology. 39:9509-9509
9509 Background: Tebentafusp (tebe) is the first T cell receptor (TCR) therapeutic to demonstrate an overall survival (OS) benefit in a randomized Phase 3 (Ph3) study [ NCT03070392 ]. In Ph2, 42% of pts with best overall response (BOR) of progressive